Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vitasora Health ( (AU:VHL) ) just unveiled an update.
Vitasora Health Limited has applied to the Australian Securities Exchange for quotation of 81,499,999 new fully paid ordinary shares, with an issue date of March 2, 2026. The securities, which follow a previously announced transaction, mark a substantial increase in the company’s listed share capital and may influence its market liquidity, ownership structure, and capacity to fund future initiatives.
The application, lodged as a new announcement on March 3, 2026, formalizes the inclusion of these additional shares under the ticker VHL. This move underscores Vitasora Health’s use of equity markets to support its corporate objectives, signalling an active approach to capital management that existing and prospective shareholders will monitor for dilution and strategic deployment of funds.
The most recent analyst rating on (AU:VHL) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Vitasora Health stock, see the AU:VHL Stock Forecast page.
More about Vitasora Health
Vitasora Health Limited, listed on the ASX under the code VHL, operates in the health sector, though the specific nature of its products, services, or target markets is not detailed in the filing. The company is expanding its equity base through the issuance of new fully paid ordinary shares to be quoted on the Australian Securities Exchange.
Average Trading Volume: 1,197,560
Technical Sentiment Signal: Sell
Current Market Cap: A$44.6M
For an in-depth examination of VHL stock, go to TipRanks’ Overview page.